Q4 2025 earnings call recap: 2026 revenue guidance, margin gains, CPT reimbursement catalyst, and consumables outlook—read now.

PROCEPT BioRobotics trades at 2.9x forward EV/2026E revenue, a deep discount to peers, despite 27-33% guided revenue growth. Learn why PRCT stock is a buy.

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025.

An Antwerp court supports India's extradition request for fugitive Mehul Choksi, dismissing his abduction claims and asylum ...

Many people dream of solid jobs with good pay, yet years of school (and mountains of debt) often stand in the way. Careers with short training paths change that picture entirely. You can enter fields ...

Plus Therapeutics (PSTV) receives AMA CPT code for CNSide test, improving reimbursement pathways and clinical adoption amid 4 ...

In an AI-native workflow, the audience for your error messages is an LLM, not a human. Compare "invalid query parameter name ...

Code assignment supports billing clarity and claims reporting for Imbed's synthetic antimicrobial wound matrix with localized, non-opioid pain management MIDDLETON, Wis., April 1, 2026 /PRNewswire/ -- ...

Although one-stage exchange may effectively treat periprosthetic joint infection, results presented here showed reimbursement ...